Using serum anti-mullerian hormone (AMH), which has been suggested to be a surrogate marker of polycystic ovarian morphology, we wished to determine if some women with IH may have the ovulatory phenotype of PCOS, where metabolic abnormalities may be more prevalent. The gene discussed is AMH; the disease is polycystic ovary syndrome.